THERMOSOME
Thermosome is an emerging biopharmaceutical company headquartered in the Innovation and Start-Up Center for Biotechnology (IZB) in Planegg/Martinsried near Munich, Germany. Our technology was invented by Prof. Dr. Hansjörg Eibl at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany, and applied, among others, in various in vitro and in vivo studies by a research group at the University Hospital of the Ludwig-Maximilians-Universitaet Munich, Germany. Based on inspiring results from this research including the preclinical proof-of-concept in various animal species, Thermosome started its operational activities in late 2015.
THERMOSOME
Industry:
Biopharma Biotechnology Medical
Founded:
2015-01-01
Address:
Munich, Bayern, Germany
Country:
Germany
Website Url:
http://www.thermosome.com
Total Employee:
1+
Status:
Active
Contact:
+4989716776031
Email Addresses:
[email protected]
Total Funding:
4.6 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default WordPress Font Awesome Wordpress Plugins Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
OxSonics Therapeutics
OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Swift Molecular Diagnostics
Swift Molecular Diagnostics is developing a rapid, easy-to-use, cost effective genetic “yes or no” test.
Current Employees Featured
Founder
Investors List
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - Thermosome
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) investment in Grant - Thermosome
Bayern Kapital
Bayern Kapital investment in Seed Round - Thermosome
Official Site Inspections
http://www.thermosome.com Semrush global rank: 7.14 M Semrush visits lastest month: 585
- Host name: sh11757.ispgateway.de
- IP address: 92.205.64.62
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "Thermosome"
Home - Thermosome
Thermosome announces the appointment of Dr. Sabine Hauck as Chief Technology Officer (CTO) more news. ASCO Annual Meeting. May 30–June 3, 2025 Chicago, USA. more Events. …See details»
Thermosome - Crunchbase Company Profile & Funding
Thermosome is an emerging biopharmaceutical company headquartered in the Innovation and Start-Up Center for Biotechnology (IZB) in Planegg/Martinsried near Munich, Germany. Our …See details»
Team - Thermosome
Pascal Schweizer is a co-founder of Thermosome and has served as the Company´s CEO since 2014. He has a wealth of international business and consulting experience with a focus on the …See details»
Thermosome - LinkedIn
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy.See details»
Thermosome GmbH - Innovations- und Gründerzentrum …
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a novel, …See details»
Thermosome's Leadership Team - Team members and org chart
About. The leadership team at Thermosome has a history of experience in the fields of health care, business, and science. Geschäftsführer at Progami Health GmbH, Geschäftsführer at …See details»
Thermosome - Contacts, Employees, Board Members, Advisors
Thermosome is developing drug candidates leveraging its proprietary drug delivery technology, New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, …See details»
Thermosome - Funding, Financials, Valuation & Investors
Thermosome is developing drug candidates leveraging its proprietary drug delivery technology, New. Resources. Advanced Search ... Experience the new Crunchbase, powered by AI . …See details»
Science - Thermosome
Thermosome’s non-invasive technology is based on proprietary thermosensitive liposomes (TSLs) using a novel, patent-protected phospholipid (DPPG 2) loaded with anticancer drugs.These …See details»
Thermosome (Thermosome GmbH) - Startbase
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a novel, …See details»
Thermosome Company Profile - Office Locations, Competitors
Thermosome is a biopharmaceutical company developing drug candidates by leveraging its proprietary drug delivery technology, which exploits a mechanism of action called intravascular …See details»
Thermosome 2025 Company Profile: Valuation, Funding
Thermosome General Information Description. Developer of a drug development platform designed to improve antitumor responses in cancer treatment. The company's platform …See details»
Thermosome - VentureRadar
Thermosome is developing drug candidates leveraging its proprietary drug delivery technology, which exploits a novel Mechanism of Action called intravascular drug release. It is our goal to …See details»
Thermosome - Company Profile - Tracxn
Feb 8, 2025 Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001GlobeNewswire • Mar 28, 2023 • Thermosome Thermosome raises €4.6m …See details»
Thermosome - OCCIDENT
Mar 13, 2024 Thermosome is a clinical-stage drug development company focused on targeted tumor therapy with immune stimulation for improved cancer therapy. At its core is a novel, …See details»
Thermosome - HTGF
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a novel, …See details»
Oncology experts to support the development of Thermosome's …
He succeeds Thermosome´s previous Chief Development Officer Dr. Klaus Fischer, who has held a freelance, part-time role and will continue to work as a consultant for Thermosome. Prof. …See details»
News - Thermosome
Independent Data Safety Monitoring Board declared dose level 2 as safe and recommended escalation to final dose level 3; Munich, Germany – December 4, 2024 – Thermosome, a …See details»
MPG spin-off Thermosome starts Phase I trial
May 24, 2023 Thermosome, a drug development company specializing in targeted tumor therapies, today announced that the first patient has been dosed in April 2023 in the ongoing …See details»
Thermosome Presents Encouraging Initial Clinical Data from Phase …
Nov 19, 2024 Thermosome’s technology enables intravascular drug release initiated by a mild heat trigger using clinically established hyperthermia devices. This results in up to 15-fold …See details»